EGFR-TKI plus brain radiotherapy versus EGFR-TKI alone in the management of EGFR-mutated NSCLC patients with brain metastases

BACKGROUND: It has been confirmed that epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) presented better efficacy than brain radiotherapy (brain RT) in the treatment of brain metastasis (BM) in EGFR mutated NSCLC patients. However, whether the combination of EGFR-TKIs and brai...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Transl Lung Cancer Res
Main Authors: Dong, Kai, Liang, Wenhua, Zhao, Shen, Guo, Minzhang, He, Qihua, Li, Caichen, Song, Haiqing, He, Jianxing, Xia, Xiaojun
Formato: Artigo
Idioma:Inglês
Publicado: AME Publishing Company 2019
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6626863/
https://ncbi.nlm.nih.gov/pubmed/31367540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2019.06.12
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares